Skip to main content
ALLR
NASDAQ Life Sciences

Allarity Therapeutics Secures 11-Year Patent Extension for Stenoparib Diagnostic, Advances Cancer Trials

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.42
Mkt Cap
$21.356M
52W Low
$0.769
52W High
$2.35
52W Position info
85% above low
Off High info
40% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ALLR sits 85% above its 52-week low of $0.769.

Summary

Allarity Therapeutics reported its first-quarter 2026 results, highlighting a strong cash position of approximately $29.8 million and a lower net loss per share compared to the prior year. Crucially, the company announced a Notice of Allowance for a U.S. patent application covering its stenoparib-specific DRP® companion diagnostic, which is expected to extend exclusivity for the drug by at least 11 years. This is a significant intellectual property win for the company's lead asset. Furthermore, clinical development for stenoparib is progressing, with a new VA-funded Phase 2 trial initiated for relapsed small cell lung cancer and continued enrollment in the FDA Fast Track designated advanced ovarian cancer trial. The Phase 3 manufacturing campaign is also on track, and new preclinical data was presented at AACR 2026. These operational and IP advancements significantly de-risk stenoparib and provide a strong positive catalyst for the company.

At the time of this announcement, ALLR was trading at $1.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.4M. The 52-week trading range was $0.77 to $2.35. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ALLR - Latest Insights

ALLR
Nov 02, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8415
Real-time Price: $0.940 info
Change: +$0.0985 (+12%) info
Market Cap: $14.482M info
ALLR
Oct 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.870
Real-time Price: $0.940 info
Change: +$0.070 (+8%) info
Market Cap: $14.482M info
ALLR
Sep 14, 2026, 12:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.21
Real-time Price: $0.940 info
Change: -$0.270 (-22%) info
Market Cap: $14.482M info
ALLR
Aug 14, 2026, 8:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $0.940 info
Change: -$0.4822 (-34%) info
Market Cap: $14.482M info
ALLR
Jul 01, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.29
Real-time Price: $0.940 info
Change: -$0.350 (-27%) info
Market Cap: $14.482M info